DACLIZUMAB - EFFECT, APPLICATION & RISKS - ACTIVE INGREDIENTS

Daclizumab



Editor'S Choice
Medicine cabinet
Medicine cabinet
Daclizumab is a therapeutic monoclonal antibody that acts against the interleukin-2 receptor (CD25). The drug was developed to reduce rejection reactions in kidney transplants. But it also has its effectiveness